Fig. 5From: Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effectBoxplots analysis for onset of neutropenia in weeks and scatterplot for correlation with age. Gender (a), Diseases (b), Treatment (c), other immune-related adverse events (d) and age in years (e). A p-value of 0.05 was defined as significantBack to article page